Stockscreener 앱 받기
1.22
1.67%
0.02
시간 외 거래:
1.24
0.02
+1.64%
전일 마감가:
$1.20
열려 있는:
$1.2
하루 거래량:
700.26K
Relative Volume:
0.29
시가총액:
$278.59M
수익:
$8.95M
순이익/손실:
$-21.49M
주가수익비율:
-10.17
EPS:
-0.12
순현금흐름:
$-29.24M
1주 성능:
+4.27%
1개월 성능:
+27.16%
6개월 성능:
+134.98%
1년 성능:
+40.07%
1일 변동 폭
$1.19
$1.23
1주일 범위
$1.14
$1.25
52주 변동 폭
$0.3651
$1.31
Lineage Cell Therapeutics Inc Stock (LCTX) Company Profile
명칭
Lineage Cell Therapeutics Inc
전화
510-871-4188
주소
2173 Salk Avenue, Suite 200, Carlsbad, CA
LCTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LCTX
Lineage Cell Therapeutics Inc
|
1.22 | 274.03M | 8.95M | -21.49M | -29.24M | -0.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Lineage Cell Therapeutics Inc Stock (LCTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-20 | 개시 | Craig Hallum | Buy |
| 2022-11-02 | 개시 | Robert W. Baird | Outperform |
| 2022-06-14 | 개시 | B. Riley Securities | Buy |
| 2021-08-19 | 개시 | Noble Capital Markets | Outperform |
| 2021-03-31 | 개시 | Cantor Fitzgerald | Overweight |
Lineage Cell Therapeutics Inc 주식(LCTX)의 최신 뉴스
Real time scanner hits for Lineage Cell Therapeutics Inc. explainedEarnings Summary Report & Community Trade Idea Sharing - Newser
Can Lineage Cell Therapeutics Inc. deliver alphaShort Setup & Growth Oriented Trading Recommendations - خودرو بانک
Published on: 2025-09-06 02:25:51 - خودرو بانک
Can Lineage Cell Therapeutics Inc. withstand a market correctionJuly 2025 Volume & Low Drawdown Investment Strategies - خودرو بانک
Combining price and volume data for Lineage Cell Therapeutics Inc.Weekly Investment Report & Fast Moving Trade Plans - Newser
Is Lineage Cell Therapeutics Inc. stock influenced by commodity pricesMarket Sentiment Report & Short-Term Trading Alerts - خودرو بانک
Should you wait for a breakout in Lineage Cell Therapeutics Inc.2025 Buyback Activity & Reliable Entry Point Alerts - Newser
How sentiment analysis helps forecast Lineage Cell Therapeutics Inc.2025 Momentum Check & Weekly Chart Analysis and Guides - Newser
How to read the order book for Lineage Cell Therapeutics Inc.Stop Loss & High Conviction Investment Ideas - Newser
How to use Fibonacci retracement on Lineage Cell Therapeutics Inc.Analyst Downgrade & Daily Volume Surge Signals - Newser
Can technical indicators confirm Lineage Cell Therapeutics Inc.’s reversal2025 Market Sentiment & Community Driven Trade Alerts - Newser
What are analysts’ price targets for Lineage Cell Therapeutics Inc.Weekly Risk Report & Low Volatility Stock Recommendations - خودرو بانک
Analyzing recovery setups for Lineage Cell Therapeutics Inc. investorsJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - Newser
Will Lineage Cell Therapeutics Inc. outperform the marketTrade Volume Summary & Verified Chart Pattern Signals - Newser
can technical indicators confirm lineage cell therapeutics inc.’s reversalGDP Growth & Stock Portfolio Risk Control - Newser
What data driven models say about Lineage Cell Therapeutics Inc.’s futureEarnings Risk Summary & Daily Technical Forecast Reports - Newser
Does Lineage Cell Therapeutics Inc. show high probability of reboundQuarterly Trade Report & Trade Opportunity Analysis Reports - Newser
Published on: 2025-09-04 04:56:57 - Newser
Published on: 2025-09-04 08:56:10 - خودرو بانک
Is it time to cut losses on Lineage Cell Therapeutics Inc.2025 EndofYear Setup & Growth Focused Stock Reports - Newser
Is Lineage Cell Therapeutics Inc. still worth holding after the dipProfit Target & Weekly Momentum Stock Picks - Newser
Does Lineage Cell Therapeutics Inc. offer margin of safetyJuly 2025 Price Swings & Reliable Trade Execution Plans - خودرو بانک
Is it too late to sell Lineage Cell Therapeutics Inc.Quarterly Performance Summary & Risk Managed Trade Strategies - Newser
Evaluating Lineage Cell Therapeutics Inc. with trendline analysisWeekly Market Summary & Fast Momentum Stock Entry Tips - Newser
Spinal Cord Injury Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights By DelveInsight | StemCyte, NervGen Pharma, VA Office of Research and Development - The Globe and Mail
Is Lineage Cell Therapeutics Inc. reversing from oversold territoryWeekly Profit Summary & Consistent Income Trade Ideas - Newser
Measuring Lineage Cell Therapeutics Inc.’s beta against major indicesWall Street Watch & Free Daily Entry Point Trade Alerts - Newser
Applying big data sentiment scoring on Lineage Cell Therapeutics Inc.Sell Signal & Smart Allocation Stock Tips - Newser
Is Lineage Cell Therapeutics Inc. forming a reversal patternJuly 2025 Intraday Action & Long-Term Investment Growth Plans - Newser
Is Lineage Cell Therapeutics Inc. stock a value trapJuly 2025 Catalysts & Weekly Breakout Watchlists - خودرو بانک
New Report: Cell Therapy Manufacturing Market Set for Rapid - openPR.com
What candlestick patterns are forming on Lineage Cell Therapeutics Inc.Volume Spike & Community Verified Swing Trade Signals - Newser
Is Lineage Cell Therapeutics Inc. forming a bottoming baseJuly 2025 Levels & Weekly High Momentum Picks - Newser
Lineage Cell Therapeutics Inc. stock prediction for this weekPortfolio Update Summary & Capital Efficiency Focused Strategies - Newser
Tick level data insight on Lineage Cell Therapeutics Inc. volatilityQuarterly Profit Summary & Detailed Earnings Play Strategies - Newser
Will breakout in Lineage Cell Therapeutics Inc. lead to full recovery2025 Growth vs Value & Scalable Portfolio Growth Methods - Newser
Does Lineage Cell Therapeutics Inc. align with a passive investing strategyJuly 2025 Technicals & Reliable Entry Point Alerts - خودرو بانک
Is Lineage Cell Therapeutics Inc. a play on infrastructure spending2025 Market WrapUp & Safe Entry Trade Reports - خودرو بانک
Spinal Cord Injury Pipeline Analysis, Clinical Trials, 2025 by DelveInsight | EUSOL Biotech, Kringle Pharma, Mitsubishi Tanabe Pharma Corporation, Lineage Cell Therapeutics, NervGen Pharma, AlaMab The - Barchart.com
Aug Spikes: Does Lineage Cell Therapeutics Inc. align with a passive investing strategy2025 Year in Review & Growth Focused Entry Reports - خودرو بانک
Published on: 2025-09-02 15:54:56 - Newser
Real time pattern detection on Lineage Cell Therapeutics Inc. stockTake Profit & Daily Profit Focused Stock Screening - Newser
Published on: 2025-09-02 13:14:02 - Newser
Comparing Lineage Cell Therapeutics Inc. in custom built stock radarsGlobal Markets & Fast Gain Stock Tips - Newser
Lineage Cell Therapeutics to Present at September 2025 Investor Conferences - 富途牛牛
Lineage Cell Therapeutics Inc (LCTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):